VANDA Pharmaceuticals - Investor Relations - IR Home

Investor Relations

SEC Filing Details

Document Details

Form
Filing Date
Aug 14, 2020
Document Date
Aug 12, 2020
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Vanda Pharmaceuticals Inc.
Issuer
Vanda Pharmaceuticals Inc.
Filer
Jones Aranthan II
Copyright © 2005-2020 Vanda Pharmaceuticals Inc. |